Month: February 2021

Feb 24 2021

Uncategorized

Schizophrenia Drugs Market To Rise At 4.3% CAGR; Increasing Cases Of Chronic and Mental Disorders Will Boost Growth, says Fortune Business Insights

by Clinical Editor

No Comments

The increasing prevalence of chronic and mental disorder is a key factor expected to enable growth in the global schizophrenia drugs market, says Fortune …

Feb 24 2021

Uncategorized

Researchers use powerful X-rays to analyze brain tissues of schizophrenia patients

by Clinical Editor

No Comments

Schizophrenia, a chronic, neurological brain disorder, affects millions of people around the world. It causes a fracture between a person’s thoughts, feelings and behavior.

Feb 24 2021

Uncategorized

Study finds schizophrenia raises risk of COVID-19 death as those with mental illness wait for vaccine

by Clinical Editor

No Comments

A study out of New York University has found that those suffering from schizophrenia are three times more likely to die from COVID-19 than those without the disorder.

Feb 24 2021

Uncategorized

Positive symptom phenotypes appear progressively in “EDiPS”, a new animal model of the schizophrenia prodrome

by Clinical Editor

No Comments

Prior to the diagnosis of schizophrenia, patients typically display attenuated positive, cognitive, and negative symptoms, during a period known as the prodrome 1. These symptoms increase in severity …

Feb 23 2021

Uncategorized

Schizophrenia: recognition and management – The Pharmaceutical Journal – The Pharmaceutical Journal

by Clinical Editor

No Comments

Schizophrenia: recognition and management – The Pharmaceutical Journal  The Pharmaceutical Journal

Feb 23 2021

Uncategorized

Positive symptom phenotypes appear progressively in “EDiPS”, a new animal model of the schizophrenia prodrome

by Clinical Editor

No Comments

Prior to the diagnosis of schizophrenia, patients typically display attenuated positive, cognitive, and negative symptoms, during a period known as the prodrome 1. These symptoms increase in severity …

Feb 23 2021

Uncategorized

Psychedelics And Schizophrenia: What’s The Link?

by Clinical Editor

No Comments

Psychedelics and schizophrenia share a history. Now, researchers are looking at how psychedelics may change the future. Can psychedelics help treat schizophrenia? LSD-25 sat on a shelf for five years...

Feb 23 2021

Uncategorized

Schizophrenia-associated SLC39A8 polymorphism is a loss-of-function allele altering glutamate receptor and innate immune signaling

by Clinical Editor

No Comments

Schizophrenia is a complex and heterogenous disease that presents with abnormalities in glutamate signaling and altered immune and inflammatory signals. Genome-wide association studies have indicated …

Feb 23 2021

Uncategorized

Artificial ‘brain in a dish’ is created that matures ‘just like a human brain’ and could shed light on conditions such as Alzheimer’s and schizophrenia

by Clinical Editor

No Comments

Extensive genetic analyses of the so-called ‘organoids’ – which were allowed to grow in experimental dishes for up to 20 months – was conducted by US researchers.

Feb 23 2021

Uncategorized

Placenta’s Role in Schizophrenia ‘Bigger Than We Imagined’

by Clinical Editor

No Comments

Schizophrenia-related genes in the placenta, coupled with a complicated pregnancy, may alter baby’s brain growth and raise the risk for schizophrenia.